V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300006168 | 300004254 | 1.66 | 79.3 | Palliative (P) | 2018-05-29 | 2018-06-26 | DE-ESCALATE TRIAL | N | null | 300014960 | TRIAL |
| 300006170 | 300004257 | 1.55 | null | Palliative (P) | 2016-11-24 | 2016-12-09 | CETUXIMAB + RT | N | null | 300014985 | CETUXIMAB + RT |
| 300006171 | 300004257 | 1.67 | 67 | Palliative (P) | 2016-07-01 | 2016-07-02 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | N | 300014985 | TRIAL |
| 300006173 | 300004260 | null | 62.2 | Palliative (P) | 2016-03-02 | 2016-03-04 | Carboplatin AUC 2 - 5 | 02 | N | 300015001 | CARBOPLATIN + ETOPOSIDE |
| 300006174 | 300004261 | 1.61 | 61.7 | Palliative (P) | 2015-09-06 | 2016-03-08 | null | N | N | 300015003 | FLUOROURACIL |
| 300006175 | 300004261 | null | 49.6 | Palliative (P) | 2014-11-23 | 2014-11-30 | Cetuximab 7 day (Cycle 1) | N | N | 300015003 | CAPECITABINE |
| 300006176 | 300008325 | 1.71 | 92.5 | Palliative (P) | 2016-09-13 | 2017-05-02 | FEC 100 | 02 | N | 300015008 | NILOTINIB |
| 300006177 | 300008325 | 1.6 | 48.5 | Palliative (P) | 2017-02-12 | 2017-02-18 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | 300015008 | CAPECITABINE + CARBOPLATIN |
| 300006178 | 300008325 | 1.6 | null | Palliative (P) | 2014-01-17 | 2014-01-20 | Cisplatin chemoembolisation | null | N | 300015008 | CISPLATIN + FLUOROURACIL |
| 300006179 | 300008349 | 1.46 | null | Palliative (P) | 2014-04-27 | 2014-06-22 | PEMBROLIZUMAB | 02 | null | 300015039 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300006180 | 300004262 | null | 91.65 | Palliative (P) | null | 2014-11-11 | Cisplatin +Fluorouracil (3 wk) | N | N | 300015041 | ESPAC TRIAL |
| 300006181 | 300004266 | 1.66 | 40 | Palliative (P) | 2017-04-07 | 2017-04-13 | VEPEMB | N | N | 300015051 | IVA |
| 300006182 | 300004266 | null | 60.8 | Palliative (P) | 2013-09-22 | 2013-09-22 | FLUOROURACIL | 2 | N | 300015051 | CAPECITABINE |
| 300006183 | 300004267 | 1.65 | 65.3 | Palliative (P) | 2015-09-14 | 2015-09-15 | Cisplatin 7 day | N | N | 300015060 | CETUXIMAB |
| 300006184 | 300004268 | 1.73 | null | Palliative (P) | 2015-10-24 | 2015-10-24 | FEC 100 + DOCETAXEL | 02 | N | 300015072 | CARBO + FLUOROURACIL |
| 300006185 | 300004269 | 1.63 | 57.95 | Palliative (P) | 2015-12-09 | 2015-12-29 | Gemcitabine + Capecitabine | N | N | 300015077 | DOCETAXEL |
| 300006186 | 300004272 | 1.63 | 71.9 | Palliative (P) | 2017-11-19 | 2017-12-13 | TOPOTECAN | N | N | 300015081 | CISPLATIN + FLUOROURACIL |
| 300006187 | 300004273 | 1.56 | null | Palliative (P) | 2016-11-10 | 2017-01-14 | Cisplatin +Fluorouracil (3 wk) | N | N | 300015086 | CAPECITABINE + GEMCITABINE |
| 300006188 | 300004274 | 1.67 | 112.5 | Palliative (P) | 2013-11-11 | 2013-12-19 | DE-ESCALATE TRIAL | null | null | 300015087 | TRIAL |
| 300006189 | 300004275 | 1.66 | 67.2 | Palliative (P) | 2015-03-09 | 2015-03-23 | CAPECITABINE + GEMCITABINE | N | N | 300015094 | TRIAL |
| 300006190 | 300004276 | 1.55 | 54.4 | Palliative (P) | 2016-03-03 | 2016-03-16 | Cisplatin + Fluorouracil + RT 5day | 02 | Y | 300015099 | CISPLATIN |
| 300006191 | 300004277 | 1.77 | 87 | Palliative (P) | 2016-06-15 | 2016-06-20 | Cetuximab 7 day (Cycle 1) | N | N | 300015107 | HYDROXYCARBAMIDE |
| 300006192 | 300004278 | 1.86 | null | Palliative (P) | 2016-10-20 | 2016-11-13 | PEMBROLIZUMAB | Y | N | 300015108 | CARBOPLATIN |
| 300006193 | 300004279 | 1.7 | 92 | Palliative (P) | 2014-07-05 | 2014-07-05 | Cetuximab 7 day (Cycle 1) | N | N | 300015111 | CAPE + CARBOPLATIN + CETUXIMAB |
| 300006197 | 300004282 | 1.6 | 55 | Palliative (P) | 2014-06-04 | 2014-06-15 | Cetuximab + Radiotherapy Maint | 02 | Y | 300015122 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006198 | 300004283 | 1.69 | 77.8 | Palliative (P) | 2013-08-12 | 2013-08-12 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | 300015127 | CARBO + FLUOROURACIL |
| 300006199 | 300004283 | 1.56 | 51.5 | Curative (C) | null | 2016-06-16 | Trial Unspecified | N | N | 300015127 | CAPECITABINE + GEMCITABINE |
| 300006200 | 300004283 | 1.81 | 84.5 | Palliative (P) | null | 2013-11-29 | Folfirinox | 02 | N | 300015127 | CISPLATIN + FLUOROURACIL |
| 300006201 | 300004286 | 1.54 | 62.2 | Palliative (P) | 2014-05-17 | 2014-05-17 | Carboplatin + Paclitaxel (weekly) | N | N | 300015152 | CISPLATIN + FLUOROURACIL |
| 300006202 | 300004286 | 1.6 | 72 | Palliative (P) | null | 2014-05-20 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 300015152 | CARBOPLATIN |
| 300006203 | 300004289 | 1.87 | 72.7 | Palliative (P) | 2014-01-23 | 2014-02-03 | Cetuximab 7 day (Cycle 1) | 02 | N | 300015158 | NOT MATCHED |
| 300006204 | 300006783 | 1.65 | null | null | 2016-05-01 | 2016-05-02 | DE-ESCALATE TRIAL | N | null | 300015159 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006205 | 300004291 | null | null | Disease modification (D) | 2016-12-23 | 2017-01-01 | Carboplatin AUC 6 - 10 | 02 | N | 300015176 | CETUXIMAB |
| 300006206 | 300004292 | 1.57 | 79 | Not known (9) | 2014-07-13 | 2014-08-13 | CETUXIMAB + RT | N | null | 300015176 | DE-ESCALATE TRIAL |
| 300006207 | 300004292 | 1.7 | 69.2 | Palliative (P) | 2017-11-27 | 2017-12-10 | Carboplatin AUC 2 - 5 | N | N | 300015176 | CAV |
| 300006208 | 300004292 | 1.59 | 76.3 | Palliative (P) | 2017-07-22 | 2017-09-07 | CISPLATIN + FLUOROURACIL | 2 | N | 300015176 | CAPECITABINE |
| 300006210 | 300004294 | 1.56 | 61.9 | Palliative (P) | 2016-08-01 | 2016-09-23 | Folfirinox | 02 | N | 300015203 | DOCETAXEL |
| 300006211 | 300004297 | 1.71 | 61.9 | Palliative (P) | 2013-11-06 | 2014-01-03 | Carboplatin AUC 2 - 5 | 2 | N | 300015204 | PEMBROLIZUMAB |
| 300006212 | 300004298 | 1.58 | null | Palliative (P) | 2017-11-16 | 2018-05-23 | Cetuximab + Radiotherapy Maint | N | null | 300015210 | DE-ESCALATE TRIAL |
| 300006213 | 300004300 | 1.75 | 58 | Palliative (P) | 2014-09-09 | 2014-09-09 | Cisplatin | N | N | 300015218 | CAPECITABINE + GEMCITABINE |
| 300006214 | 300004301 | 1.6 | 54.2 | Palliative (P) | 2014-11-07 | 2014-11-08 | CARBOPLATIN + RT | 02 | Y | 300015219 | CARBOPLATIN + RT |
| 300006215 | 300004302 | 0 | 60 | Palliative (P) | 2013-05-09 | 2013-05-09 | Irinotecan + Modified De Gramont | 02 | N | 300015225 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 300006216 | 300004303 | 1.82 | 47 | Palliative (P) | 2016-09-30 | 2016-09-30 | Capecitabine + Oxaliplatin 21day | 2 | N | 300015230 | OXALIPLATIN + MDG |
| 300006217 | 300004304 | 1.7 | 56.3 | Palliative (P) | 2015-06-04 | 2015-07-30 | Nilotinib | N | N | 300015236 | CARBOPLATIN |
| 300006218 | 300004305 | 1.66 | 101 | Palliative (P) | null | 2014-12-21 | Carboplatin AUC 2 - 5 | N | N | 300015251 | CARBOPLATIN |
| 300006219 | 300004307 | 1.84 | 70.4 | Palliative (P) | 2016-07-16 | 2016-07-24 | Gemcitabine + Capecitabine | 02 | N | 300015255 | CISPLATIN + FLUOROURACIL |
| 300006220 | 300004308 | 1.83 | 57.3 | Palliative (P) | 2015-09-27 | 2015-12-28 | ESPAC-4 TRIAL | 02 | null | 300015255 | CAPECITABINE + GEMCITABINE |
| 300006221 | 300004308 | 1.84 | null | Palliative (P) | 2014-12-13 | 2015-01-24 | STAMPEDE TRIAL | 02 | N | 300015255 | CETUXIMAB + RT |
| 300006222 | 300004308 | null | null | Palliative (P) | 2014-09-20 | 2014-11-15 | Cisplatin | N | N | 300015255 | CISPLATIN |
| 300006223 | 300004310 | 1.58 | 60.6 | Palliative (P) | 2016-09-21 | 2016-10-11 | CARBOPLATIN + PACLITAXEL | 02 | N | 300015280 | NIVOLUMAB |